Use of an Acute Seroconversion Panel To Evaluate a Third-Generation Enzyme-Linked Immunoassay for Detection of Human Immunodeficiency Virus-Specific Antibodies Relative to Multiple Other Assays
- 1 May 2006
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 44 (5) , 1856-8
- https://doi.org/10.1128/jcm.44.5.1856-1858.2006
Abstract
A human immunodeficiency virus type 1 (HIV-1)/HIV-2 antibody screening assay, the Genetic Systems HIV-1/HIV-2 PLUS O EIA, was compared to several established screening or confirmatory tests using an acute HIV seroconversion panel. The HIV-1/HIV-2 PLUS O EIA showed an improved sensitivity over all tested antibody screening methods, and detected antibody in 7 of 19 specimens found to be negative by a first-generation EIA but positive for the presence of HIV RNA.Keywords
This publication has 14 references indexed in Scilit:
- Targeted screening for primary HIV infection through pooled HIV-RNA testing in men who have sex with menAIDS, 2005
- Dynamics of HIV viremia and antibody seroconversion in plasma donorsAIDS, 2003
- Evaluation of a new third generation anti-HIV-1/anti-HIV-2 assay with increased sensitivity for HIV-1 group OJournal of Virological Methods, 1996
- Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassaysJournal of Virological Methods, 1995
- Sensitivity of HIV-antibody assays determined by seroconversion panelsAIDS, 1994
- Sensitivity of United States HIV antibody tests for detection of HIV-1 group O infectionsThe Lancet, 1994
- HIV-1/HIV-2 seronegativity in HIV-1 subtype 0 infected patientsThe Lancet, 1994
- Quantitation of HIV: Correlation with clinical, virological, and immunological statusJournal of Medical Virology, 1991
- Transient High Levels of Viremia in Patients with Primary Human Immunodeficiency Virus Type 1 InfectionNew England Journal of Medicine, 1991
- Efficacies of US Food and Drug Administration-licensed HIV-1-screening enzyme immunoassays for detecting antibodies to HIV-2AIDS, 1990